Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.38 HKD | -0.67% | -4.53% | -5.99% |
Mar. 28 | Aim Vaccine Submits Pre-Applications for Clinical Trials for Two Vaccines; Shares Up 3% | MT |
Mar. 28 | Aim Vaccine's Loss Quadruples in 2023 as Revenue Slips 6%; Shares Up 3% | MT |
Sales 2024 * | 3.41B 470M 3.67B | Sales 2025 * | 4.67B 645M 5.04B | Capitalization | 8.35B 1.15B 9B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.72 x |
Net Debt 2024 * | 904M 125M 975M | Net Debt 2025 * | 575M 79.38M 620M | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,624 |
Yield 2024 * |
1.84% | Yield 2025 * |
3.5% | Free-Float | 22.09% |
1 day | -0.67% | ||
1 week | -4.53% | ||
Current month | -12.56% | ||
1 month | -11.93% | ||
3 months | +9.01% | ||
6 months | -18.00% | ||
Current year | -5.99% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Wen Guan
PSD | President | 57 | 16-11-30 |
Li Xin Niu
DFI | Director of Finance/CFO | 52 | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lun Ma
BRD | Director/Board Member | 62 | 15-11-30 |
Xin Zhou
BRD | Director/Board Member | 55 | 13-04-30 |
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 7.38 | -0.67% | 752 400 |
24-05-27 | 7.43 | +0.68% | 2,515,200 |
24-05-24 | 7.38 | -1.34% | 235,200 |
24-05-23 | 7.48 | -1.58% | 173,200 |
24-05-22 | 7.6 | -1.68% | 305,800 |
Delayed Quote Hong Kong S.E., May 28, 2024 at 04:08 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.99% | 1.15B | |
-1.64% | 90.28B | |
-1.84% | 39.5B | |
-15.83% | 31.71B | |
+63.12% | 26.41B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.8B | |
-45.77% | 10.95B | |
+3.37% | 8.85B |
- Stock Market
- Equities
- 6660 Stock